Pharmesis International Ltd. provided earnings guidance for the six months ended June 30, 2022. For the period, the company expected net loss was mainly due to the control measures such as lockdowns taken by China to contain the spread of the COVID-19 pandemic, which has resulted in a decrease in sales.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.111 SGD | -7.50% | -7.50% | +13.27% |
1st Jan change | Capi. | |
---|---|---|
+13.27% | 2.27M | |
+26.08% | 662B | |
+21.85% | 546B | |
-4.77% | 359B | |
+16.97% | 323B | |
+5.69% | 290B | |
+13.68% | 234B | |
+3.65% | 198B | |
-11.12% | 194B | |
-3.40% | 157B |
- Stock Market
- Equities
- BFK Stock
- News Pharmesis International Ltd.
- Pharmesis International Ltd. Provides Earnings Guidance for the Six Months Ended June 30, 2022